The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
is it a Bank Holiday tomorrow? ;)
I've had the same feeling SpaceTomato, too many product and development conflicts that their own pipelines are built upon. They're not going to want to wreck them and re-invent quickly. Having said that, AVA6000 could set the cat amongst the pigeons for all the generic competing chemotherapies.
I'd want them to be holding off any bids and the board saying: let's bank this money first, see-through AVA6000, develop the antibody alternative to a greater extent and then see who, if anyone, can afford us...
ABCAM deal may already be baiting interest. Would be a shame not to see through AVA6000 & TMAC in particular.
What I love about this Company is all of these things going on in the background: distributors, licensing, partnering, collaboration and exponential innovation. It truly is a remarkable opportunity like no other.
Early May I think Saffrob
I’ve a feeling that although the AVA6000 data may be 6-8 months from now, it will be apparent if it’s succeeding very soon after first dosing, at least from a curbing side effects point of view. If it does work, it will be pretty impossible for the immediate trial impact to be kept quiet.
Wise words Italyal
Congrats to all those who called it so well this morning, thoroughly deserved.
I imagine Borat would sell the TTG device well for use in Kazakhstani nightclubs
I’m sure the director RNS was sent mid afternoon today so as not to clog up the red button at 7am tomorrow morn. ;)
Aside from the 2 dips over the last week, the SP has become pretty resilient. Of course no one really likes to see the dips, it builds unnecessary insecurity.
At the end of the day, few of us have focused as much on research for a company in our lives as this one. To a large extent the opportunity has come about in freaky circumstances- was almost ordained.
All of the evidence is still abundantly clear and the great quality from this board has certainly helped provide that. There is every reason this will begin to properly fly any day now. I think the only surprises we may have in store will be unexpectedly good ones.
Don't think you'll need one Infinis, once it gets to that point. Things will be moving so quickly and most likely will continue during this year as each new manufacturing deal comes on board and then personally I'd have to see it through this summer's clinical trials before I took a bean.
a bit more patience needed. Waiting will bring our great rewards:
https://www.bing.com/videos/search?q=tom+hanks+the+terminal+I+wait+scene&docid=608026035388419033&mid=FBEFBE6985A94654CBB5FBEFBE6985A94654CBB5&view=detail&FORM=VIRE
It'll be his 'year after lockdown' talk and his hindsight "sorry I forgot to think of closing the airports'
1st lockdown anniversary
and the opportunity to demonstrate we have THE best test on the world..
Interesting read, thanks for the link Energy.
What a year we have ahead of us. If part one isn’t big enough anyway to keep us panting, we have the AVA6000 sequel summer onwards which could be an even bigger blockbuster.
It’s impossible to imagine not wanting to see the sequel all the way through, of course if it’s still in our hands by then.
One of the things that was worthwhile in yesterday’s video was that Al sounded pretty confident in his tone with regards the overseas scale up. This is the part that has been hard to assess but news on multiple overseas manufacturers could come anytime and quite regularly. Our numbers would escalate dramatically ongoing.